[The protective activity of anti-Proteus blood preparations].
Human blood anti-Proteus preparation activity has been studied on the model of Proteus etiology sepsis in white not pedigree mice. It has been found out that anti-Proteus plasma and anti-Proteus immunoglobulin with antibody titre 1:80 possess marked therapeutic properties. The obtained results of the experimental studies are the grounds for clinical studies carrying out with the use of blood anti-Proteus preparations in combined therapy of the patients with diseases of Proteus etiology.
Nazarchuk
L V
LV
Kiev Research Institute of Hematology and Blood Transfusion.
Koval'
A I
AI
D000818:Animals; D000907:Antibodies, Bacterial / Q000627:therapeutic use*; D001770:Blood Bactericidal Activity; D004306:Dose-Response Relationship, Immunologic; D005069:Evaluation Studies as Topic; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D051379:Mice; D010949:Plasma / Q000276:immunology*; D011512:Proteus Infections / Q000473:pathology / Q000628:therapy*; D011513:Proteus mirabilis / Q000276:immunology* / Q000472:pathogenicity; D018805:Sepsis / Q000473:pathology / Q000628:therapy*; D014774:Virulence
D000907:Antibodies, Bacterial